The FDA says compounding pharmacies have to stop making tirzepatide because the agency has declared the yearlong Zepbound shortage over. The deadline is Wednesday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,